Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Download PDF
June 28, 2016
/
News
Share
the Post
Related
Posts
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
Support letter for inclusion of Daclatasvir on 4th March, 2015.
New WHO guideline on care and treatment of chronic hepatitis C
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Part 2: How is hepatitis C treated?
Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
